Tomiyasu Murata

1.5k total citations
86 papers, 1.3k citations indexed

About

Tomiyasu Murata is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tomiyasu Murata has authored 86 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 32 papers in Oncology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tomiyasu Murata's work include Bioactive natural compounds (12 papers), Drug Transport and Resistance Mechanisms (12 papers) and Signaling Pathways in Disease (10 papers). Tomiyasu Murata is often cited by papers focused on Bioactive natural compounds (12 papers), Drug Transport and Resistance Mechanisms (12 papers) and Signaling Pathways in Disease (10 papers). Tomiyasu Murata collaborates with scholars based in Japan, United States and Slovakia. Tomiyasu Murata's co-authors include Masayoshi Yamaguchi, Norio Kaneda, Chihiro Ito, Masataka Itoigawa, M. Neale Weitzmann, Satoru Osuka, Hiroshi Furukawa, Mamoru Shoji, Keisuke Nakao and Masaru Tsuboi and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Biochemical Journal.

In The Last Decade

Tomiyasu Murata

84 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomiyasu Murata Japan 20 789 279 154 151 138 86 1.3k
Chang-Mo Kang South Korea 13 887 1.1× 242 0.9× 89 0.6× 178 1.2× 94 0.7× 18 1.3k
Rong Fan China 27 820 1.0× 302 1.1× 191 1.2× 95 0.6× 148 1.1× 55 1.8k
Mingxia Zhao China 17 613 0.8× 157 0.6× 150 1.0× 101 0.7× 200 1.4× 37 1.3k
Qiujuan Wang China 18 635 0.8× 100 0.4× 161 1.0× 105 0.7× 90 0.7× 49 1.2k
Song Xu China 26 893 1.1× 170 0.6× 238 1.5× 86 0.6× 152 1.1× 65 1.6k
Sun-Hee Kim South Korea 21 657 0.8× 245 0.9× 72 0.5× 94 0.6× 83 0.6× 35 1.2k
Jagan M.R. Patlolla United States 19 796 1.0× 228 0.8× 79 0.5× 85 0.6× 126 0.9× 34 1.5k
Monica Savio Italy 25 1.2k 1.6× 569 2.0× 164 1.1× 143 0.9× 136 1.0× 44 2.1k
Chuan‐Ming Xie China 18 738 0.9× 187 0.7× 81 0.5× 98 0.6× 69 0.5× 42 1.3k
Shih‐Hsin Tu Taiwan 22 1.1k 1.4× 375 1.3× 134 0.9× 73 0.5× 84 0.6× 68 1.7k

Countries citing papers authored by Tomiyasu Murata

Since Specialization
Citations

This map shows the geographic impact of Tomiyasu Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomiyasu Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomiyasu Murata more than expected).

Fields of papers citing papers by Tomiyasu Murata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomiyasu Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomiyasu Murata. The network helps show where Tomiyasu Murata may publish in the future.

Co-authorship network of co-authors of Tomiyasu Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Tomiyasu Murata. A scholar is included among the top collaborators of Tomiyasu Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomiyasu Murata. Tomiyasu Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Masayoshi, Tomiyasu Murata, & Noriaki Shimokawa. (2025). Overexpression of RGPR‐p117 reveals anticancer effects by regulating multiple signaling pathways in bone metastatic human breast cancer MDA‐MB‐231 cells. IUBMB Life. 77(1). e2939–e2939. 1 indexed citations
2.
3.
Yamaguchi, Masayoshi, Kazunori Hashimoto, Mayumi Jijiwa, & Tomiyasu Murata. (2023). The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-α and IL-6 signaling: Involvement of cell signaling regulator regucalcin. Cellular Signalling. 107. 110663–110663. 12 indexed citations
4.
Hashimoto, Kazunori, et al.. (2023). Higher N2 gas-flow rate ratios in O2- and Ar-containing feed gas mixtures enhance the cytotoxic effects of radical-activated medium against murine melanoma B16F10 cells. Japanese Journal of Applied Physics. 62(12). 127001–127001. 1 indexed citations
5.
Yamaguchi, Masayoshi, Tomiyasu Murata, & Joe W. Ramos. (2022). Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells. The Prostate. 82(10). 1025–1039. 5 indexed citations
6.
Murata, Tomiyasu, Kazunori Hashimoto, Susumu Kohno, et al.. (2021). Chemical inducer of regucalcin attenuates lipopolysaccharide‐induced inflammatory responses in pancreatic MIN6 β‐cells and RAW264.7 macrophages. FEBS Open Bio. 12(1). 175–191. 4 indexed citations
7.
Murata, Tomiyasu, et al.. (2020). Regucalcin enhances adipocyte differentiation and attenuates inflammation in 3T3‐L1 cells. FEBS Open Bio. 10(10). 1967–1984. 10 indexed citations
8.
Yamaguchi, Masayoshi, Tomiyasu Murata, & Joe W. Ramos. (2020). The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin. Molecular and Cellular Biochemistry. 472(1-2). 173–185. 4 indexed citations
9.
Yamaguchi, Masayoshi, Satoru Osuka, Tomiyasu Murata, & Joe W. Ramos. (2020). Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells. Translational Oncology. 14(1). 100955–100955. 9 indexed citations
10.
Murata, Tomiyasu, Tomoki Nakayoshi, Akifumi Oda, et al.. (2020). (S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells. Bioorganic & Medicinal Chemistry. 30. 115904–115904. 3 indexed citations
11.
Takeuchi, Yuto, Kuniki Kato, Tomiyasu Murata, et al.. (2020). Induction of enantio-selective apoptosis in human leukemia HL-60 cells by (S)-erypoegin K, an isoflavone isolated from Erythrina poeppigiana. Bioorganic & Medicinal Chemistry. 28(11). 115490–115490. 8 indexed citations
12.
Shi, Wei, Yujia Wang, Junzheng Peng, et al.. (2019). EPHB6 controls catecholamine biosynthesis by up-regulating tyrosine hydroxylase transcription in adrenal gland chromaffin cells. Journal of Biological Chemistry. 294(17). 6871–6887. 9 indexed citations
13.
Yamaguchi, Masayoshi, Satoru Osuka, M. Neale Weitzmann, et al.. (2016). Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro. International Journal of Oncology. 49(4). 1686–1694. 28 indexed citations
14.
Yamaguchi, Masayoshi & Tomiyasu Murata. (2015). Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro. Molecular Medicine Reports. 12(5). 7801–7805. 8 indexed citations
15.
Yamaguchi, Masayoshi & Tomiyasu Murata. (2013). Involvement of regucalcin in lipid metabolism and diabetes. Metabolism. 62(8). 1045–1051. 48 indexed citations
16.
Yamaguchi, Masayoshi, M. Neale Weitzmann, Clifton A. Baile, & Tomiyasu Murata. (2012). Exogenous regucalcin suppresses osteoblastogenesis and stimulates adipogenesis in mouse bone marrow culture. Integrative Biology. 4(10). 1215–1215. 20 indexed citations
17.
Ito, Chihiro, Masataka Itoigawa, Keisuke Nakao, et al.. (2005). Induction of apoptosis by carbazole alkaloids isolated from Murraya koenigii. Phytomedicine. 13(5). 359–365. 108 indexed citations
18.
19.
Murata, Tomiyasu, et al.. (2000). Characterization of the 5′-flanking region of the rat TIS11 gene. Molecular and Cellular Biochemistry. 214(1). 1–6. 2 indexed citations
20.
Murata, Tomiyasu & Masayoshi Yamaguchi. (1997). Molecular cloning of the cDNA coding for regucalcin and its mRNA expression in mouse liver: The expression is stimulated by calcium administration. Molecular and Cellular Biochemistry. 173(1-2). 127–133. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang-Mo Kang Breakdown of academic impact, for papers by Rong Fan Breakdown of academic impact, for papers by Mingxia Zhao Breakdown of academic impact, for papers by Qiujuan Wang Breakdown of academic impact, for papers by Song Xu Breakdown of academic impact, for papers by Sun-Hee Kim Breakdown of academic impact, for papers by Jagan M.R. Patlolla Breakdown of academic impact, for papers by Monica Savio Breakdown of academic impact, for papers by Chuan‐Ming Xie Breakdown of academic impact, for papers by Shih‐Hsin Tu
Rankless by CCL
2026